Autopsy report · NCT00944229
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
Cause of deathStaffing, sites or logistics
“PI left the institution”
Life of this trial
- Registered 11 months before it started.
- Ran for about 4 years 2 months before it stopped.
- 58 participants enrolled.
- Results were posted on the registry 2 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Conditions
- Heart Failure
- Interventions
- LOVAZA (Omega-3); Placebo
- Participants
- 58
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Impact of Strength and Power Training on Golf Performance and Swing Biomechanics
“PI has left the institution.” - Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
“Former PI Left the Institution” - Prospective Study of Induction Medications Used in the Trauma RSI
“PI left institution.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.